Eyenovia to end eye drug study, cut 50% of its workforce
Eyenovia said on Friday it will discontinue a late-stage study for its experimental drug-device combination to treat near-sightedness and cut about 50% of its workforce.
Eyenovia to end eye drug study after missing late-stage goal, shares fall
(Reuters) -Eyenovia will discontinue a late-stage study for its experimental drug-device combination to treat near-sightedness in children after it failed to slow the condition's progression, sending ...